Bioventus Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
BVS Nasdaq 3850 www.bioventus.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bioventus Inc.

Are Investors Undervaluing Bioventus (BVS) Right Now? - Jun 9th, 2026 7:40 am
Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls - Jun 8th, 2026 5:03 pm
Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year? - Jun 3rd, 2026 7:40 am
After Plunging 22% in 4 Weeks, Here's Why the Trend Might Reverse for Bioventus (BVS) - Jun 2nd, 2026 7:35 am
Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference - Jun 2nd, 2026 5:00 am
Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - May 29th, 2026 7:55 am
Is Bioventus (BVS) Stock Undervalued Right Now? - May 21st, 2026 7:40 am
Are Medical Stocks Lagging Bioventus (BVS) This Year? - May 18th, 2026 7:40 am
Consumer Sentiment Just Crashed Below the Recession Threshold. These 3 Defensive Stocks Under $25 Are Built for What Comes Next - May 14th, 2026 9:47 am
Bioventus' (NASDAQ:BVS) Solid Earnings Are Supported By Other Strong Factors - May 14th, 2026 6:12 am
Wall Street Analysts See a 38.97% Upside in Bioventus (BVS): Can the Stock Really Move This High? - May 8th, 2026 7:55 am
Bioventus Inc. Q1 2026 Earnings Call Summary - May 6th, 2026 2:48 pm
Bioventus (BVS) Q1 2026 Earnings Transcript - May 6th, 2026 1:49 pm
Bioventus Q1 Earnings Call Highlights - May 6th, 2026 8:55 am
Bioventus (BVS) Surpasses Q1 Earnings and Revenue Estimates - May 6th, 2026 7:05 am
Bioventus Reports First Quarter Financial Results - May 6th, 2026 5:30 am
Should Value Investors Buy Bioventus (BVS) Stock? - May 5th, 2026 7:40 am
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues - Apr 30th, 2026 2:43 pm
Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now? - Apr 29th, 2026 7:40 am
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026 - Apr 28th, 2026 2:15 pm